MedPath

SELEPEN INJ 40MCG/ML USP

SELEPEN INJ 40MCG/ML USP

Discontinued
DIN Number

01945335

Drug Class

Human

Market Date

Dec 31, 1984

Company
HC

lyphomed, division of fujisawa canada inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number01945335
AIG Number0106697007
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
B05XA31 ELECTROLYTES IN COMB WITH OTHER DRUGS
Product Specifications
Dosage FormLiquid
Route of AdministrationIntravenous
AHFS Classification40:12.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

SELENIUM (SELENIOUS ACID)Active
Strength: 40 MCG / ML
Monograph: SELENIUM (SELENIOUS ACID)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.